Business
Chimeric (ASX:CHM) share price drops despite cancer trial update
Image Source: Getty Images
The Chimeric Therapeutics Ltd (ASX: CHM) share price has fallen today. It coincides with the drug development company’s update on its cancer cell therapy.
At market’s close, the Chimeric share price was trading at 29 cents, down…
Continue Reading
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News17 hours agoForum responds to urgent homelessness issues in Nambour
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoFirst home buyers score early access to deposit scheme